APA (7th ed.) Citation

M, Y., A, T., S, M., R, C., J, T., A, M., . . . LG, L. (2023). Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 x Anti-GD2 Bispecific Antibody Armed T cells. Research square. https://doi.org/10.21203/rs.3.rs-3570311/v1

Chicago Style (17th ed.) Citation

M, Yankelevich, et al. "Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 X Anti-GD2 Bispecific Antibody Armed T Cells." Research Square 2023. https://doi.org/10.21203/rs.3.rs-3570311/v1.

MLA (9th ed.) Citation

M, Yankelevich, et al. "Targeting GD2-positive Refractory/Resistant Neuroblastoma and Osteosarcoma with Anti- CD3 X Anti-GD2 Bispecific Antibody Armed T Cells." Research Square, 2023, https://doi.org/10.21203/rs.3.rs-3570311/v1.